当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析 - 现金流量表

海正药业

(600267)

  

流通市值:127.49亿  总市值:127.56亿
流通股本:11.98亿   总股本:11.99亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金5,791,576,436.272,722,682,572.5411,130,442,232.98,365,256,571.78
  收到的税费返还6,656,615.082,041,364.0427,607,365.4751,151,542.76
  收到其他与经营活动有关的现金310,601,342.47118,896,415.48355,882,736.34346,239,911.16
  经营活动现金流入小计6,108,834,393.822,843,620,352.0611,513,932,334.718,762,648,025.7
  购买商品、接受劳务支付的现金2,541,822,928.511,432,232,724.075,206,426,097.554,133,920,000.21
  支付给职工以及为职工支付的现金960,409,709.4584,417,014.411,619,570,942.531,250,583,656.89
  支付的各项税费431,873,697210,531,098.21653,679,236.69500,267,049.09
  支付其他与经营活动有关的现金963,693,649.24353,732,450.381,850,162,521.391,422,297,458.74
  经营活动现金流出小计4,897,799,984.152,580,913,287.079,329,838,798.167,307,068,164.93
  经营活动产生的现金流量净额1,211,034,409.67262,707,064.992,184,093,536.551,455,579,860.77
二、投资活动产生的现金流量:
  取得投资收益收到的现金11,544,400-16,975,438.3615,910,438.36
  处置固定资产、无形资产和其他长期资产收回的现金净额3,410,361.323,044,406.4911,234,586.311,008,640.96
  收到的其他与投资活动有关的现金3,416,283.821,529,219.45422,180,877.5921,630,248.26
  投资活动现金流入小计18,371,045.144,573,625.94450,390,902.2638,549,327.58
  购建固定资产、无形资产和其他长期资产支付的现金112,627,963.2748,824,111.48238,441,690.76116,365,516.18
  投资支付的现金30,784,936.6525,000,00039,234,450.4639,234,450.46
  支付其他与投资活动有关的现金2,229,894.351,086,791.4463,075,679.983,248,813.19
  投资活动现金流出小计145,642,794.2774,910,902.88740,751,821.2158,848,779.83
  投资活动产生的现金流量净额-127,271,749.13-70,337,276.94-290,360,918.94-120,299,452.25
三、筹资活动产生的现金流量:
  取得借款收到的现金1,195,029,200.48569,343,2304,092,067,7963,152,000,000
  收到其他与筹资活动有关的现金--300,000,000300,000,000
  筹资活动现金流入小计1,195,029,200.48569,343,2304,392,067,7963,452,000,000
  偿还债务支付的现金1,531,217,796613,000,0004,337,170,0002,947,021,551.78
  分配股利、利润或偿付利息支付的现金299,991,018.8727,731,374.33148,471,078.7112,231,571.14
  支付其他与筹资活动有关的现金56,613,187.871,679,317.361,943,371,911.021,866,982,094.27
  筹资活动现金流出小计1,887,822,002.74642,410,691.696,429,012,989.724,926,235,217.19
  筹资活动产生的现金流量净额-692,792,802.26-73,067,461.69-2,036,945,193.72-1,474,235,217.19
四、汇率变动对现金及现金等价物的影响677,653.7559,053.483,474,327.912,597,714.07
  现金及现金等价物净增加额平衡项目0-0.0100
五、现金及现金等价物净增加额391,647,512.03119,361,379.83-139,738,248.2-136,357,094.6
  加:期初现金及现金等价物余额1,189,884,406.71,189,884,406.71,329,622,654.911,329,622,654.91
  期末现金及现金等价物余额1,581,531,918.731,309,245,786.531,189,884,406.711,193,265,560.31
补充资料:
  净利润304,913,629.54-591,311,870.59-
  资产减值准备142,462,387.53-219,020,280.63-
  固定资产和投资性房地产折旧426,759,845.36-884,578,982.87-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧426,759,845.36-884,578,982.87-
  无形资产摊销57,508,038.08-188,708,557.99-
  长期待摊费用摊销1,540,903.45-3,426,783.36-
  处置固定资产、无形资产和其他长期资产的损失-305,012.36--722,661.2-
  固定资产报废损失325,243.78-1,272,666.38-
  公允价值变动损失35,878,704.73-14,926,284.66-
  财务费用53,587,757.24-151,270,555.46-
  投资损失29,880,317.54--162,959,494.8-
  递延所得税28,933,138.19-7,021,826.85-
  其中:递延所得税资产减少28,950,839.67-4,401,215.35-
    递延所得税负债增加-17,701.48-2,620,611.5-
  存货的减少128,612,507.42-69,128,178.62-
  经营性应收项目的减少108,333,202.62-157,914,218.44-
  经营性应付项目的增加-118,131,538.34--47,679,097.62-
  其他323,184.74-5,993,066.62-
  债务转为资本--429.26-
  现金的期末余额1,581,531,918.73-1,189,884,406.7-
  减:现金的期初余额1,189,884,406.7-1,329,622,654.91-
  现金及现金等价物的净增加额391,647,512.03--139,738,248.21-
公告日期2025-08-262025-04-172025-03-292024-10-31
审计意见(境内)标准无保留意见
TOP↑